Pathstone Holdings
NEO icon

Pathstone Holdings’s NeoGenomics NEO Stock Holding History

Pathstone Holdings’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-21,126
Closed -$157K – 2396
2026
Q1 		$157K Sell
21,126
-342
-2% -$3.6K ﹤0.01% 2135
2025
Q4 		$252K Sell
21,468
-27,003
-56% -$291K ﹤0.01% 2021
2025
Q3 		$374K Buy
48,471
+9,732
+25% +$68.2K ﹤0.01% 1917
2025
Q2 		$283K Buy
38,739
+16,161
+72% +$130K ﹤0.01% 1945
2025
Q1 		$215K Sell
22,578
-6,839
-23% -$85.4K ﹤0.01% 2055
2024
Q4 		$485K Sell
29,417
-3,002
-9% -$46.6K ﹤0.01% 1732
2024
Q3 		$478K Sell
32,419
-680
-2% -$10.6K ﹤0.01% 1747
2024
Q2 		$459K Sell
33,099
-2,889
-8% -$41K ﹤0.01% 1736
2024
Q1 		$566K Sell
35,988
-239
-0.7% -$3.69K ﹤0.01% 1627
2023
Q4 		$586K Buy
+36,227
New +$593K ﹤0.01% 1402

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Pathstone Holdings's NEO Position: Q2 2026 in Review

Pathstone Holdings sold out of NeoGenomics (NEO) in Q2 2026, closing a stake of 21,126 shares — an estimated $157K sold.

Pathstone Holdings first reported a position in NEO in Q4 2023 and held it in 10 quarters. The position peaked at $586K in Q4 2023. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Pathstone Holdings reported no remaining NeoGenomics position as of Q2 2026 after selling out during the quarter.
  • Pathstone Holdings sold 21,126 NeoGenomics shares in Q2 2026, an estimated $157K.
  • Pathstone Holdings first reported a position in NeoGenomics in Q4 2023 and held it in 10 quarters.
  • Pathstone Holdings's NeoGenomics position peaked at $586K in Q4 2023.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.